ICON Clinical Research

About ICON Clinical Research

ICON Clinical Research is a leading global provider of outsourced development and commercialisation services to the pharmaceutical, biotechnology, and medical device industries. With a commitment to advancing clinical research, ICON offers a comprehensive range of services that span the entire drug development process.

Founded in 1990, ICON has grown significantly, establishing a strong presence in over 40 countries worldwide. The company prides itself on its innovative approach to clinical trials, leveraging cutting-edge technology and data analytics to enhance efficiency and improve patient outcomes.

Core Services:

• Clinical Trial Management
• Regulatory Affairs
• Data Management and Biostatistics
• Patient Recruitment and Retention
• Market Access and Commercialisation Strategies

ICON’s mission is to support its clients in bringing new therapies to market faster and more efficiently. The company collaborates closely with its clients, providing tailored solutions that meet their specific needs and challenges.

With a dedicated team of over 15,000 professionals, ICON is committed to maintaining the highest standards of quality and compliance in all its operations. The company’s vision is to be the partner of choice for the life sciences industry, driving innovation and excellence in clinical research.

Through its extensive experience and expertise, ICON Clinical Research continues to play a pivotal role in transforming the future of healthcare.